Blocking glycan production by targeting GALNT7 for prostate cancer therapy.
0/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.9%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
APA
Peng Z, Hodgson K, et al. (2026). Blocking glycan production by targeting GALNT7 for prostate cancer therapy.. Expert opinion on therapeutic targets, 30(2), 87-92. https://doi.org/10.1080/14728222.2026.2619761
MLA
Peng Z, et al.. "Blocking glycan production by targeting GALNT7 for prostate cancer therapy.." Expert opinion on therapeutic targets, vol. 30, no. 2, 2026, pp. 87-92.
PMID
41556382 ↗
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Neural Network Guided Global Least Squares for Quantitative Biochemical Component Analysis in Raman Spectroscopy.
- PMM2 interacts with TRIM28 to recruit E2F4 and promote KIFC3-mediated tumor glycolysis and colorectal cancer progression.
- Comments on: stage-specific impact of portal hypertension on outcomes after liver resection in hepatocellular carcinoma.
- Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial.
- Trastuzumab deruxtecan in patients from China with previously treated human epidermal growth factor receptor 2-positive locally advanced/metastatic gastric or gastroesophageal junction adenocarcinoma (DESTINY-Gastric06): results from a single-arm, multicenter, phase 2 trial.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Transforming Growth Factor-β Drives Epithelial Mesenchymal Transition and Reduces Synthesis of Unelaborated O-GalNAc Glycans in Breast Cancer Cells.
- Presentation Is Essential for Glycan-Lectin Recognition at the Molecular and Cellular Levels: The Interaction of Tumor-Associated ‑Glycans with the Macrophage Galactose-Type Lectin.
- Deletion of Core 1 β3GalT-specific molecular chaperone (Cosmc) in murine intestinal epithelia leads to major alterations in glycocalyx and tumorigenesis.
- Tumor-associated Tn and STn antigens: from molecular mechanism to precision diagnosis and treatment.
- GALNT7 promotes hepatocellular carcinoma progression by activating the PI3K/AKT signaling pathway via O-glycosylation of MUC13.
- Sialyl-Tn glycan epitope as a target for pancreatic cancer therapies.